OBJECTIVES: To explore the possible role of serum lipoprotein(a) (Lp(a)), apolipoprotein E polymorphism, and total cholesterol (TC) serum concentrations in Alzheimer's disease (AD). METHODS: Lp(a) serum concentrations, apolipoprotein E genotypes, and TC serum concentrations were determined in 61 patients with a diagnosis of probable AD and in 63 healthy unrelated age matched controls. Genomic DNA was obtained and amplified by polymerase chain reaction and apolipoprotein E genotypes were defined following a previously described procedure. RESULTS: Lp(a) serum concentrations were significantly associated in a non-linear relation with an increased risk for AD, independently of apolipoprotein E genotypes and sex and dependent on age (truth association) and TC serum concentrations (spurious association). The effect of age adjusted for TC on the odds of having AD increased non-linearly with increasing Lp(a) serum concentrations, with a plateau between 70 and 355 mg/l (odds ratio 11.33). For Lp(a) serum concentrations > or = 360 mg/l, the effect of age (> or = 72 years) was associated with a reduction in odds of having AD (odds ratio 0.15). CONCLUSION: It is suggested that increased Lp(a) serum concentrations, by increasing the risk for cerebrovascular disease, may have a role in determining clinical AD.
OBJECTIVES: To explore the possible role of serum lipoprotein(a) (Lp(a)), apolipoprotein E polymorphism, and total cholesterol (TC) serum concentrations in Alzheimer's disease (AD). METHODS:Lp(a) serum concentrations, apolipoprotein E genotypes, and TC serum concentrations were determined in 61 patients with a diagnosis of probable AD and in 63 healthy unrelated age matched controls. Genomic DNA was obtained and amplified by polymerase chain reaction and apolipoprotein E genotypes were defined following a previously described procedure. RESULTS:Lp(a) serum concentrations were significantly associated in a non-linear relation with an increased risk for AD, independently of apolipoprotein E genotypes and sex and dependent on age (truth association) and TC serum concentrations (spurious association). The effect of age adjusted for TC on the odds of having AD increased non-linearly with increasing Lp(a) serum concentrations, with a plateau between 70 and 355 mg/l (odds ratio 11.33). For Lp(a) serum concentrations > or = 360 mg/l, the effect of age (> or = 72 years) was associated with a reduction in odds of having AD (odds ratio 0.15). CONCLUSION: It is suggested that increased Lp(a) serum concentrations, by increasing the risk for cerebrovascular disease, may have a role in determining clinical AD.
Authors: F Panza; V Solfrizzi; F Torres; F Mastroianni; A M Colacicco; A M Basile; C Capurso; A D'Introno; A Del Parigi; A Capurso Journal: Neurosci Lett Date: 2000-10-06 Impact factor: 3.046
Authors: F Panza; V Solfrizzi; F Torres; F Mastroianni; A Del Parigi; A M Colacicco; A M Basile; C Capurso; R Noya; A Capurso Journal: Neurosci Lett Date: 1999-12-17 Impact factor: 3.046
Authors: D L Eaton; G M Fless; W J Kohr; J W McLean; Q T Xu; C G Miller; R M Lawn; A M Scanu Journal: Proc Natl Acad Sci U S A Date: 1987-05 Impact factor: 11.205
Authors: Joshua B Owen; Rukhsana Sultana; Christopher D Aluise; Michelle A Erickson; Tulin O Price; Guojun Bu; William A Banks; D Allan Butterfield Journal: Free Radic Biol Med Date: 2010-10-07 Impact factor: 7.376
Authors: Alana C Costa; Helena P G Joaquim; Valéria S Nunes; Daniel S Kerr; Guilherme S Ferreira; Orestes V Forlenza; Wagner F Gattaz; Leda Leme Talib Journal: Eur Arch Psychiatry Clin Neurosci Date: 2017-08-31 Impact factor: 5.270
Authors: Nicholus M Warstadt; Emily L Dennis; Neda Jahanshad; Omid Kohannim; Talia M Nir; Katie L McMahon; Greig I de Zubicaray; Grant W Montgomery; Anjali K Henders; Nicholas G Martin; John B Whitfield; Clifford R Jack; Matt A Bernstein; Michael W Weiner; Arthur W Toga; Margaret J Wright; Paul M Thompson Journal: Neurobiol Aging Date: 2014-06-02 Impact factor: 4.673
Authors: Gerson T Lesser; Vahram Haroutunian; Dushyant P Purohit; Michal Schnaider Beeri; James Schmeidler; Linda Honkanen; Richard Neufeld; Leslie S Libow Journal: Dement Geriatr Cogn Disord Date: 2009-01-08 Impact factor: 2.959